Connor, Clark & Lunn Investment Management (CC&L)’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.18M | Sell |
|
|||||
|
2024
Q4 | $2.05M | Buy |
|
|||||
|
2024
Q3 | $1.17M | Buy |
|
|||||
|
2024
Q2 | $923K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.05M | Sell |
|
|||||
|
2023
Q3 | $405K | Buy |
|
|||||
|
2023
Q2 | $261K | Sell |
|
|||||
|
2023
Q1 | $381K | Sell |
|
|||||
|
2022
Q4 | $1.77M | Buy |
|
|||||
|
2022
Q3 | $1.01M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $816K | Buy |
|
|||||
|
2019
Q2 | $611K | Sell |
|
|||||
|
2019
Q1 | $1.78M | Buy |
|
|||||
|
2018
Q4 | $1.95M | Buy |
|
|||||
|
2018
Q3 | $1.84M | Sell |
|
|||||
|
2018
Q2 | $2.25M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $602K | Buy |
|